SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | -95.1% | 140 | -89.1% | 0.00% | -100.0% |
| Q1 2019 | $204,000 | -45.6% | 1,280 | -67.3% | 0.01% | -55.6% |
| Q4 2018 | $375,000 | -40.9% | 3,911 | -12.8% | 0.02% | -21.7% |
| Q3 2018 | $634,000 | -11.9% | 4,485 | -2.5% | 0.02% | -14.8% |
| Q2 2018 | $720,000 | -97.1% | 4,602 | -97.0% | 0.03% | -97.3% |
| Q1 2018 | $24,630,000 | -11.4% | 152,913 | -9.4% | 0.99% | -7.8% |
| Q4 2017 | $27,801,000 | +489.6% | 168,785 | +123.0% | 1.07% | +457.8% |
| Q3 2017 | $4,715,000 | -67.6% | 75,679 | -58.6% | 0.19% | -68.4% |
| Q2 2017 | $14,559,000 | +41.3% | 182,804 | +26.1% | 0.61% | +43.7% |
| Q1 2017 | $10,306,000 | – | 145,018 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |